Drug Search Results
More Filters [+]

Ondelopran

Alternative Names: ondelopran
Latest Update: 2018-09-10
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: OPR Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Russia

Approved Indications: None

Known Adverse Events: None

Company: R-Pharm
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Ondelopran

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Alcoholism

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CN07006005

P3

Completed

Alcoholism

2016-04-16

81%

CN07006005

P3

Completed

Alcoholism

2016-04-16

81%

Recent News Events

Date

Type

Title